Product Name:

NebuSelect™ Recombinant Canine PRLR, hFc-tag

Catalog#:

NBL-242186

Description:

NebuSelect™ Recombinant Canine PRLR, hFc-tag(Cat#NBL-242186) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Gln25-Thr235.

Species:

Canine

Expression System:

HEK293

Molecular Weight: 

The protein has a predicted MW of 53.89 kDa. Due to glycosylation, the protein migrates to 65-70 kDa based on Bis-Tris PAGE result.

Target Name:

PRLR; PRL-R; HPRL; MFAB; Prolactin R

Target Information:

Prolactin receptor (PRLR) is highly expressed in a subset of human breast cancer and prostate cancer, which makes it a potential target for cancer treatment. In clinical trials, the blockade of PRLR was shown to be safe but with poor efficacy. It is therefore urgent to develop new therapies against PRLR target. Bispecific antibodies (BsAbs) could guide immune cells toward tumor cells, and produced remarkable effects in some cancers.

Amino Acid Sequence: 

Gln25-Thr235

Purity:

＞95%

Formulation:

see COA

Endotoxin:

＜1EU/ug(LAL Method)

Storage: 

4°C for short term. 

-20°C for long term.

To get more information, please contact us freely.